AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2017
Jun 3, 2017
31046_dirs_2017-06-02_fff66c6e-e367-49e4-a50d-ad816832ae4e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-05-31
Reporting Person: Souza Marcio (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 36457 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right To Buy) | $26.42 | 2024-07-31 | Common Stock (30000.0) | Direct | |
| Stock Option (Right To Buy) | $51.0 | 2025-01-02 | Common Stock (10525.0) | Direct | |
| Stock Option (Right To Buy) | $30.86 | 2026-01-03 | Common Stock (16000.0) | Direct | |
| Stock Option (Right To Buy) | $12.64 | 2026-11-16 | Common Stock (2000.0) | Direct | |
| Stock Option (Right To Buy) | $11.23 | 2027-01-02 | Common Stock (23100.0) | Direct | |
| Stock Option (Right To Buy) | $12.92 | 2027-05-17 | Common Stock (10000.0) | Indirect |
Footnotes
F1: Includes 4,000 shares of a Restricted stock award awarded to the Reporting Person, which vests in four equal annual installments over four years, commencing on January 3, 2018.
F2: This option was granted on July 31, 2014 and vests over four years, with 25% of the shares underlying the option vested on July 31, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 31, 2015.
F3: This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.
F4: This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F5: This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
F6: This option was granted on January 3, 2017 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
F7: This option was granted on May 17, 2017 and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018.